Zoledronic acid in pediatric metabolic bone disorders

被引：30

作者：

Bowden, Sasigarn A. ^{[1
]}

Mahan, John D. ^{[2
]}

机构：

[1] Ohio State Univ, Dept Pediat, Coll Med, Div Endocrinol,Nationwide Childrens Hosp, Columbus, OH 43210 USA

[2] Ohio State Univ, Dept Pediat, Coll Med, Div Nephrol,Nationwide Childrens Hosp, Columbus, OH 43210 USA

来源：

TRANSLATIONAL PEDIATRICS | 2017年 / 6卷 / 04期

关键词：

Zoledronic acid (ZA); osteoporosis; fragility fractures; bone mineral density (BMD); metabolic bone disease; hypercalcemia; osteonecrosis (ON); acute phase reaction (APR); SEVERE CEREBRAL-PALSY; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; INTRAVENOUS BISPHOSPHONATE THERAPY; ACUTE LYMPHOBLASTIC-LEUKEMIA; DUCHENNE MUSCULAR-DYSTROPHY; ACUTE-PHASE RESPONSE; SHORT-TERM SAFETY; OSTEOGENESIS-IMPERFECTA; MINERAL DENSITY; PHARMACOLOGICAL PROFILE;

D O I：

10.21037/tp.2017.09.10

中图分类号：

R72 [儿科学];

学科分类号：

100202 [儿科学];

摘要：

Zoledronic acid (ZA), a highly potent intravenous bisphosphonate (BP), has been increasingly used in children with primary and secondary osteoporosis due to its convenience of shorter infusion time and less frequent dosing compared to pamidronate. Many studies have also demonstrated beneficial effects of ZA in other conditions such as hypercalcemia of malignancy, fibrous dysplasia (FD), chemotherapy-related osteonecrosis (ON) and metastatic bone disease. This review summarizes pharmacologic properties, mechanism of action, dosing regimen, and therapeutic outcomes of ZA in a variety of metabolic bone disorders in children. Several potential novel uses of ZA are also discussed. Safety concerns and adverse effects are also highlighted.

引用

页码：256 / 268

页数：13

共 79 条

[51]

Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic review [J].

Mergler, Sandra ;

Evenhuis, Heleen M. ;

Boot, Annemieke M. ;

De Man, Stella A. ;

Bindels-De Heus, Karen G. C. B. ;

Huijbers, Wim A. R. ;

Penning, Corine .

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2009, 51 (10) :773-778

[52]

Histomorphometry and Bone Matrix Mineralization Before and After Bisphosphonate Treatment in Boys With Duchenne Muscular Dystrophy: A Paired Transiliac Biopsy Study [J].

Misof, Barbara M. ;

Roschger, Paul ;

McMillan, Hugh J. ;

Ma, Jinhui ;

Klaushofer, Klaus ;

Rauch, Frank ;

Ward, Leanne M. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2016, 31 (05) :1060-1069

[53]

Acute phase response and mineral status following low dose intravenous zoledronic acid in children [J].

Munns, Craig F. ;

Rajab, Mansoor H. ;

Hong, Janet ;

Briody, Julie ;

Hoegler, Wolfgang ;

McQuade, Mary ;

Little, David G. ;

Cowell, Christopher T. .

BONE, 2007, 41 (03) :366-370

[54]

Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite [J].

Nancollas, G. H. ;

Tang, R. ;

Phipps, R. J. ;

Henneman, Z. ;

Gulde, S. ;

Wu, W. ;

Mangood, A. ;

Russell, R. G. G. ;

Ebetino, F. H. .

BONE, 2006, 38 (05) :617-627

[55]

Zoledronic acid improves bone mineral density in pediatric spinal cord injury [J].

Ooi, Hooi Leng ;

Briody, Julie ;

McQuade, Mary ;

Munns, Craig F. .

JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (07) :1536-1540

[56]

Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL) [J].

Padhye, Bhavna ;

Dalla-Pozza, Luciano ;

Little, David ;

Munns, Craig .

CANCER MEDICINE, 2016, 5 (05) :960-967

[57]

Response to zolendronic acid in children with type III osteogenesis imperfecta [J].

Panigrahi, Inusha ;

Das, Rashmi Ranjan ;

Sharda, Sheetal ;

Marwaha, Ram Kumar ;

Khandelwal, Niranjan .

JOURNAL OF BONE AND MINERAL METABOLISM, 2010, 28 (04) :451-455

[58]

Zoledronate Derivatives as Potential Inhibitors of Uridine Diphosphate-Galactose Ceramide Galactosyltransferase 8: A Combined Molecular Docking and Dynamic Study [J].

Pannuzzo, Giovanna ;

Graziano, Adriana Carol Eleonora ;

Pannuzzo, Martina ;

Masman, Marcelo Fabricio ;

Avola, Rosanna ;

Cardile, Venera .

JOURNAL OF NEUROSCIENCE RESEARCH, 2016, 94 (11) :1318-1326

[59]

Park Hye-Jin, 2016, Ann Pediatr Endocrinol Metab, V21, P99, DOI 10.6065/apem.2016.21.2.99

[60]

Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study [J].

Plotkin, Horacio ;

Coughlin, Susan ;

Kreikemeier, Rose ;

Heldt, Kathryn ;

Bruzoni, Matias ;

Lerner, Gary .

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2006, 48 (09) :709-712

← 1 2 3 4 5 6 7 8 →